Health Insurance Coverage Limitations of Anti-Integrin Therapy in Ulcerative Colitis and Their Impact on Anti-Tumor Necrosis Factor (Anti-TNF) Therapy Utilization

被引:0
|
作者
John, Eric [1 ]
机构
[1] Spherix Global Insights, Exton, PA USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S801
引用
收藏
页码:S371 / S371
页数:1
相关论文
共 50 条
  • [41] Outcomes of anti-TNF versus Vedolizumab therapy for ulcerative colitis: the Leeds experience
    Lenti, M. V.
    Johnston, A.
    O'Connor, A.
    Selinger, C.
    Ford, A. C.
    Hamlin, P. J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S192 - S193
  • [42] Assessment of the Process of Mucosal Healing in Ulcerative Colitis Upon Anti-TNF Therapy
    Hundorfean, Gheorghe
    Chiriac, Mircea T.
    Hartmann, Arndt
    Neurath, Markus F.
    Mudter, Jonas
    GASTROINTESTINAL ENDOSCOPY, 2012, 75 (04) : 173 - 174
  • [43] Anti-TNF therapy reduces ionising radiation exposure in patients with ulcerative colitis
    Aggarwal, D.
    Limdi, J. K.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S302 - S302
  • [44] THE ASSOCIATION OF INTRAEPITHELIAL IMMUNE COMPARTMENT WITH RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS
    Jha, Divya
    Al-taie, Zainab
    Krek, Azra
    Eshghi, Shadi
    Tankelevich, Michael
    Meringer, Hadar
    Cossarini, Francesca
    Canales-Herrerias, Pablo
    Livanos, Alexandra
    Polydorides, Alexandros D.
    Ko, Huaibin M.
    McBride, Jacqueline M.
    Hackney, Jason A.
    Yuan, Guo-Cheng
    Colombel, Jean Frederic
    Argmann, Carmen A.
    Suarez-Farinas, Mayte
    Petralia, Francesca
    Mehandru, Saurabh
    GASTROENTEROLOGY, 2024, 166 (05) : S1403 - S1403
  • [45] OUTCOMES OF ANTI-TNF VERSUS VEDOLIZUMAB THERAPY FOR ULCERATIVE COLITIS: THE LEEDS EXPERIENCE
    Johnston, A. J.
    Lenti, M.
    O'Connor, A.
    Selinger, C.
    Ford, A. C.
    Hamlin, P. J.
    GUT, 2017, 66 : A152 - A152
  • [46] Influence of Anti-TNF alpha Therapy on postoperative Morbidity in Patients with Ulcerative Colitis
    Groene, J.
    COLOPROCTOLOGY, 2018, 40 (05) : 375 - 376
  • [47] Efficacy of anti-tumor necrosis factor (anti-TNF) treatment in a tertiary uveitis service in the United Kingdom
    Steptoe, Paul J.
    Broadbent, Deborah
    Stylianides, Amira
    Beare, Nick
    Mewar, Devesh
    Pearce, Ian
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [48] ANTI-TNF THERAPY REDUCES IONISING RADIATION EXPOSURE IN PATIENTS WITH ULCERATIVE COLITIS
    Aggarwal, D.
    Limdi, J. K.
    GUT, 2014, 63 : A156 - A156
  • [49] Reactivation of Hepatitis B (HBV) in Patients Treated with Anti-Tumor Necrosis Factor (anti-TNF) Agents
    Pauly, Mary Patricia
    Tucker, Lue-Yen
    Szpakowski, Jean-Luc
    Baer, David
    Ready, Joanna B.
    Hwang, Jessica P.
    Lok, Anna S.
    HEPATOLOGY, 2014, 60 : 232A - 233A
  • [50] Successful Switch of Patients with Rheumatoid Arthritis Developing Anti-tumor Necrosis Factor (anti-TNF)-induced Lupus to Another Anti-TNF Agent Reply
    Jacob, Noam
    Jacob, Chaim O.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1217 - 1218